Notice2023-11370
Morris & Dickson Co., LLC; Order
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
May 30, 2023
Issuing agencies
Justice DepartmentDrug Enforcement Administration
Full Text
<html>
<head>
<title>Federal Register, Volume 88 Issue 103 (Tuesday, May 30, 2023)</title>
</head>
<body><pre>
[Federal Register Volume 88, Number 103 (Tuesday, May 30, 2023)]
[Notices]
[Pages 34522-34523]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2023-11370]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. 18-31]
Morris & Dickson Co., LLC; Order
On May 19, 2023, I issued and served on the parties a Decision and
Order (the Decision and Order) revoking, effective 30 days from the
date of publication in the Federal Register, Certificate of
Registration Nos. RM0314790 and RM0335732 issued to Morris & Dickson,
Co., LLC (Respondent). By motion dated May 20, 2023, Respondent
requested a stay of the Decision and Order. On May 21, I issued an
order soliciting additional information from Respondent and asking the
Government to respond to Respondent's Motion for Stay. On May 22, both
parties responded. Respondent clarified that it was requesting a stay
of at least 90-to-120 days so that it can renew settlement negotiations
with the Government. Respondent's May 22, 2023 Letter re Motion for
Stay, at 1. Respondent also stated that a stay was necessary to
mitigate the impact on its ``customers, employees, and other
stakeholders,'' including pharmacies, hospitals, and patients. Id. at
4-5. The Government indicated that it opposed any stay request, but
stated that it was ``open to settlement offers'' and suggested it was
willing to engage in settlement negotiations with Respondent.
Government's Opposition to Motion to Stay, at 3.
Upon consideration of the entire record before me, the public
interest--in particular, the potential need for Respondent's customers
and their patients to find new suppliers given the revocation of
Respondent's registrations--and the possibility for renewed settlement
negotiations, I hereby order that the May 19, 2023 Decision and Order
will be effective on August 28, 2023--ninety days from the date of the
Decision and Order's publication in the Federal Register. This change
is reflected in the published Decision and Order.
It is so ordered.
Signing Authority
This document of the Drug Enforcement Administration was signed on
May 23, 2023, by Administrator Anne Milgram. That document with the
original signature and date is maintained by DEA. For administrative
purposes only, and in compliance with requirements of the Office of the
Federal Register, the undersigned DEA Federal Register Liaison Officer
has been authorized to sign and submit the
[[Page 34523]]
document in electronic format for publication, as an official document
of DEA. This administrative process in no way alters the legal effect
of this document upon publication in the Federal Register.
Scott Brinks,
Federal Register Liaison Officer, Drug Enforcement Administration.
[FR Doc. 2023-11370 Filed 5-26-23; 8:45 am]
BILLING CODE 4410-09-P
</pre></body>
</html>Indexed from Federal Register on May 30, 2023.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.